申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04735952A1
公开(公告)日:1988-04-05
This invention provides a piperidine compound of the formula: ##STR1## wherein R.sup.1 is hydrogen or trihalomethyl, R.sup.2 is hydrogen or protected carboxy, R.sup.3 is heterocyclic group or aryl which may be halogen substituted, and X is --S--, ##STR2## --O--, --NH-- or lower alkylene which may be hydroxy substituted, and pharmaceutically acceptable salt thereof, These compounds possess hypotensive activity and are useful as anti-hypertensive agents. The invention further relates to processes for the preparation of these compounds and pharmaceutical compositions comprising compounds of the above formula.
本发明提供一种哌啶化合物,其化学式为:##STR1## 其中R.sup.1是氢或三卤甲基,R.sup.2是氢或保护羧基,R.sup.3是杂环基或芳基,可以是卤素取代的,X是--S--,##STR2## --O--,--NH--或低碳链,可以是羟基取代的,以及其药学上可接受的盐。这些化合物具有降压活性,可用作降压剂。本发明还涉及制备这些化合物的方法和包含上述化合物的药物组成物。